Trial Profile
The Effect of Empagliflozin Versus Metformin on Hormonal, Metabolic and Cardiovascular Risk Factors in Patients With Polycystic Ovary Syndrome (PCOS) - a Randomised Open-label Parallel Study
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Empagliflozin (Primary) ; Metformin
- Indications Polycystic ovary syndrome
- Focus Therapeutic Use
- 12 Jul 2018 Status changed from recruiting to completed.
- 30 Sep 2017 Status changed from not yet recruiting to recruiting.
- 22 Jul 2017 Planned initiation date changed from 1 Jun 2017 to 1 Aug 2017.